In a study of 80 newly diagnosed breast cancer patients commencing TAM adjuvant treatment, the plasma concentrations of endoxifen after four months were lower in patients homozygous or heterozygous for non-functional CYP2D6 alleles compared to those with two functional alleles [4]. Here, CYP2D6 is linked to breast cancer.